Kellokumpu-Lehtinen, P.; Bergh, J.; Salminen, E.; Wiklund, T.; Lehtinen, S.; Aronen, P.; Sintonen, H. Cost-Effectiveness of Intensive Adjuvant Chemotherapy for High-Risk Breast Cancer: Is Tailored and Dose-Escalated Chemotherapy With Growth Factor Support (GFS) More Costly and Less Effective Than Marrow-Supported High-Dose Chemotherapy – Results from a Ra. AO 2007, 46, 146-152.